BackgroundThe mRNA-based COVID-19 vaccine was introduced to the general public in December 2020. Shortly thereafter. safety concerns were raised due to the reporting of allergic reactions. Allergy-related disorders were suspected to be significant risk factors and the excipient polyethylene glycol was suggested to be a robust allergen. https://parisnaturalfoodes.shop/product-category/promasil-chocolate/